PK
Pankaj Kumar
Astellas Pharma (United States), Demeetra, Institute of Microbial Technology CSIR, CytomX Therapeutics (United States)
0000-0001-8650-5250
Employment
-
Astellas Pharma (United States) Lead- Antibody Engineering & Platform Tech Dev2025 - Present
-
Demeetra Protein Engineering Scientist2024 - Present
-
CytomX Therapeutics (United States) Group Leader2022 - 2024
-
Jamia Hamdard Assistant Professor2018 - 2021
-
Sonoval SME-Protein Engineering & Consultant2017 - 2022
-
Johns Hopkins University SENIOR FELLOW- Medicine2014 - 2017
-
Johns Hopkins University Howard Hughes Medical Institute Research Associate2011 - 2014
Education
-
Institute of Microbial Technology CSIR PhD2005 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- Structural basis for the role of C-terminus acidic tail of Saccharomyces cerevisiae ubiquitin-conjugating enzyme (Rad6) in E3 ligase (Bre1) mediated recognition of histones Save
- 96well-formatted CrfA assay for differentiation of Mycobacterium tuberculosis and Non-tuberculous mycobacteria Save
- Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide Save
- A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria Save
- Inhibitors of riboflavin biosynthetic pathway enzymes as potential antibacterial drugs. Save
- Epigenetic regulations in Mycobacterium tuberculosis infection Save
- Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: potential broad-spectrum therapeutic targets against infectious diseases Save
- The linker domain of the initiator DnaA contributes to its ATP binding and membrane association in E. coli chromosomal replication Save
- Glby, Encoded by MAB_3167c , Is Required for In Vivo Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity Save
- Allosteric cooperation in β-lactam binding to a non-classical transpeptidase Save